BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12855811)

  • 1. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation.
    Dumas JJ; Kumar R; Seehra J; Somers WS; Mosyak L
    Science; 2003 Jul; 301(5630):222-6. PubMed ID: 12855811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha.
    Celikel R; McClintock RA; Roberts JR; Mendolicchio GL; Ware J; Varughese KI; Ruggeri ZM
    Science; 2003 Jul; 301(5630):218-21. PubMed ID: 12855810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.
    Huizinga EG; Tsuji S; Romijn RA; Schiphorst ME; de Groot PG; Sixma JJ; Gros P
    Science; 2002 Aug; 297(5584):1176-9. PubMed ID: 12183630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biology. A ménage à trois in two configurations.
    Sadler JE
    Science; 2003 Jul; 301(5630):177-9. PubMed ID: 12855796
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
    Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation.
    Fukuda K; Doggett T; Laurenzi IJ; Liddington RC; Diacovo TG
    Nat Struct Mol Biol; 2005 Feb; 12(2):152-9. PubMed ID: 15665869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The many faces of platelet glycoprotein Ibalpha--thrombin interaction.
    Kobe B; Guncar G; Buchholz R; Huber T; Maco B
    Curr Protein Pept Sci; 2009 Dec; 10(6):551-8. PubMed ID: 19751194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the interaction between thrombin exosite 1 and the sequence 269-287 [correction of 269-297] of platelet glycoprotein Ibalpha.
    Bouton MC; Thurieau C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Aug; 80(2):310-5. PubMed ID: 9716158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity.
    Li CQ; Ye P; Cao Zf ; Wang H; Lu L; Nicastro P; Wood E; Robert JJ; Ouwehand WH; Hill F; López JA; Wardell MR
    Protein Expr Purif; 2001 Jul; 22(2):200-10. PubMed ID: 11437595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GpIbα interacts exclusively with exosite II of thrombin.
    Lechtenberg BC; Freund SM; Huntington JA
    J Mol Biol; 2014 Feb; 426(4):881-93. PubMed ID: 24316004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and characterization of rhesus monkey platelet glycoprotein Ibα, a major ligand-binding subunit of GPIb-IX-V complex.
    Qiao J; Shen Y; Shi M; Lu Y; Cheng J; Chen Y
    Thromb Res; 2014 May; 133(5):817-25. PubMed ID: 24560895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
    Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
    Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between GPIbalpha and FcgammaIIA receptor in human platelets.
    Sun B; Li J; Kambayashi Ji
    Biochem Biophys Res Commun; 1999 Dec; 266(1):24-7. PubMed ID: 10581159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
    Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
    Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
    Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
    Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
    Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of platelet activation by thrombin: a short history.
    De Candia E
    Thromb Res; 2012 Mar; 129(3):250-6. PubMed ID: 22137742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomedicine. Contact--how platelets touch von Willebrand factor.
    Sadler JE
    Science; 2002 Aug; 297(5584):1128-9. PubMed ID: 12183613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.